{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:19:57Z","timestamp":1780503597832,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> We aimed to summarize the clinical characteristics of Floating-Harbor syndrome (FHS) and the effect of recombinant human growth hormone (rhGH) to increase height.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The clinical manifestations, gene sequencing results, treatment, and regression of one child with FHS were reported at the Department of Pediatrics, General Hospital of Tianjin Medical University, in July 2020. PubMed was searched using the keyword \u201cFloating-Harbor Syndrome\u201d up to March 2021 to obtain clinical information on children with FHS for review.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The child, who was a male aged 6 years and 9 months, presented to the clinic with main complaints of delayed language development since childhood and a short stature for 4 years. The child's short stature, peculiar facial features, delayed language development, and delayed bone development were considered alongside genetic testing and Sanger sequencing to verify the results. A heterozygous mutation (c.7401delC; p.Ile2468Phefs<jats:sup>*<\/jats:sup>7) was identified in exon 34 of the <jats:italic>SRCAP<\/jats:italic> gene, which was a frameshift mutation, and Sanger verification showed that neither parent had this mutation. The child was administered subcutaneous injection of rhGH (0.13 U\/kg\/day) and was followed up regularly. At the time of writing, the child had been treated for 6 months and was 7 years and 3 months old with a height of 106.3 cm (\u22123.69 SDS), which was a height increase of 6.3 cm. The patient did not complain of discomfort during treatment and presented normal laboratory tests results. Twenty-two children with FHS treated with rhGH were included in the literature review, and most of these patients demonstrated an increase in height SDS without adverse effects.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Short stature, delayed skeletal maturation, impaired language expression, intellectual deficits, and peculiar facial features are the main clinical features of FHS. rhGH can be used as a treatment to increase height in patients with FHS, but its effectiveness and safety still need to be monitored in larger sample sizes over longer periods of time.<\/jats:p>","DOI":"10.3389\/fped.2021.747353","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:01:35Z","timestamp":1636120895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Floating-Harbor Syndrome Treated With Recombinant Human Growth Hormone: A Case Report and Literature Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Hui","family":"Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1750-1172-8-63","article-title":"The phenotype of Floating-Harbor syndrome: clinical characterization of 52 individuals with mutations in exon 34 of SRCAP","volume":"8","author":"Nikkel","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13023-019-1111-8","article-title":"Novel genotypes and phenotypes among Chinese patients with Floating-Harbor syndrome","volume":"14","author":"Zhang","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.14310\/horm.2002.1314","article-title":"Growth hormone deficiency: an unusual presentation of floating harbor syndrome","volume":"10","author":"Galli-Tsinopoulou","year":"2011","journal-title":"Hormones."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000503782","article-title":"Growth and clinical characteristics of children with Floating-Harbor syndrome: analysis of current original data and a review of the literature","volume":"92","author":"Homma","year":"2019","journal-title":"Horm Res Paediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.6065\/apem.1938144.072","article-title":"Effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome","volume":"25","author":"Son","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12881-014-0127-0","article-title":"Expanded spectrum of exon 33 and 34 mutations in SRCAP and follow-up in patients with Floating-Harbor syndrome","volume":"15","author":"Seifert","year":"2014","journal-title":"BMC Med Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ajmg.a.36314","article-title":"Long-term follow-up study for a patient with Floating-Harbor syndrome due to a hotspot SRCAP mutation","author":"Nagasaki","year":"2014","journal-title":"Am J Med Genet A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF03343962","article-title":"Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome","volume":"25","author":"Cannav\u00f2","year":"2002","journal-title":"J Endocrinol Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ajmg.1585","article-title":"Floating-Harbor syndrome in two unrelated girls: mild short stature in one patient and effective growth hormone therapy in the other","volume":"104","author":"Wieczorek","year":"2001","journal-title":"Am J Med Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1515\/JPEM.2007.20.12.1333","article-title":"Precocious puberty in a girl with floating-harbor syndrome","volume":"20","author":"Stagi","year":"2007","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/jpem.2011.406","article-title":"Clinical and genetic characteristics and effects of long-term growth hormone therapy in a girl with Floating-Harbor syndrome","volume":"25","author":"Garc\u00eda","year":"2012","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B12","first-page":"8","article-title":"Case report 1","volume":"1","author":"Pelletier","year":"1973","journal-title":"Syndr Identif."},{"key":"B13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(75)92351-X","article-title":"The Floating-Harbor syndrome","volume":"11","author":"Leisti","year":"1975","journal-title":"Birth Defects Orig Artic Ser."},{"key":"B14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jmedgenet-2016-103842","article-title":"When chromatin organisation floats astray: the Srcap gene and Floating-Harbor syndrome","volume":"53","author":"Messina","year":"2016","journal-title":"J Med Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/humu.22216","article-title":"Not all floating-harbor syndrome cases are due to mutations in exon 34 of SRCAP","volume":"34","author":"Le Goff","year":"2013","journal-title":"Hum Mutat."},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2478\/bjmg-2018-0005","article-title":"Floating-Harbor syndrome: presentation of the first Romanian patient with a SRCAP mutation and review of the literature","volume":"21","author":"Budisteanu","year":"2018","journal-title":"Balkan J Med Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1002\/ajmg.a.35635","article-title":"Floating-Harbor syndrome and polycystic kidneys associated with SRCAP mutation","author":"Reschen","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pedhc.2018.07.009","article-title":"Renal calculus in Floating-Harbor syndrome: a case report","volume":"33","author":"Shields","year":"2019","journal-title":"J Pediatr Health Care."},{"key":"B19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrendo.2015.165","article-title":"Short and tall stature: a new paradigm emerges","volume":"11","author":"Baron","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1302\/2058-5241.5.190088","article-title":"The growth plate: a physiologic overview","volume":"5","author":"Agirdil","year":"2020","journal-title":"EFORT Open Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ajmg.a.30760","article-title":"Floating-Harbor syndrome complicated by tethered cord: a new association and potential contribution from growth hormone therapy","volume":"136","author":"Wiltshire","year":"2005","journal-title":"Am J Med Genet A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/ajmg.a.33033","article-title":"Floating-Harbor syndrome associated with middle ear abnormalities","author":"Hendrickx","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"103785","DOI":"10.1016\/j.ejmg.2019.103785","article-title":"Intracranial vascular pathology in two further patients with Floating-Harbor syndrome: proposals for cerebrovascular disease risk management","volume":"63","author":"Menzies","year":"2020","journal-title":"Eur J Med Genet."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.747353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:01:37Z","timestamp":1636120897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.747353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":23,"alternative-id":["10.3389\/fped.2021.747353"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.747353","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"article-number":"747353"}}